Keywords: Alzheimer's disease, Agitation, Memantine, Ebixa, Namanda

Alzheimer's drug memantine fails to reduce significant agitation

Article | 03 May 2012

Print This

Memantine, a drug prescribed for Alzheimer's disease, does not ease clinically significant agitation in patients, according to a new study ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in